- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT03010150
Blodprøver og spørgeskemaer til undersøgelse af overholdelse af forebyggende synkeøvelser hos deltagere med metastatisk hoved- og nakkekræft
Modellering af overholdelse af forebyggende synkeøvelser ved hoved- og nakkekræft
This trial uses blood tests and questionnaires to study how well participants with head and neck cancer that has spread to other places in the body adhere to swallowing exercises to prevent future disease. Using blood tests to study cytokines (proteins related to the immune system) may help doctors learn if certain levels of cytokines affect whether or not side effects occur and if they put participants at risk for future disease. Questionnaires may help doctors learn about the reasons head and neck cancer participants may or may not follow the swallowing exercises that they are asked to perform after receiving radiation treatments.
Studieoversigt
Status
Betingelser
- Klinisk trin III HPV-medieret (p16-positiv) orofaryngealt karcinom AJCC v8
- Stadium III Hypopharyngeal Carcinom AJCC v8
- Fase III Larynxcancer AJCC v8
- Stadie III Oropharyngeal (p16-negativ) karcinom AJCC v8
- Stadie IV Hypopharyngeal Carcinom AJCC v8
- Fase IV Larynxcancer AJCC v8
- Stadie IV Oropharyngeal (p16-negativ) karcinom AJCC v8
- Klinisk fase I HPV-medieret (p16-positiv) orofarynxcarcinom AJCC v8
- Klinisk fase II HPV-medieret (p16-positiv) orofaryngealt karcinom AJCC v8
- Patologisk stadie I HPV-medieret (p16-positiv) orofaryngealt karcinom AJCC v8
- Patologisk fase II HPV-medieret (p16-positiv) orofaryngealt karcinom AJCC v8
- Stadie IV Nasopharyngeal Carcinoma AJCC v8
- Patologisk trin III HPV-medieret (p16-positiv) orofarynxcarcinom AJCC v8
- Stadie IVA Nasopharyngeal Carcinoma AJCC v8
- Stadie IVB Nasopharyngeal Carcinom AJCC v8
- Stadie IVA Hypopharyngeal Carcinoma AJCC v8
- Stage IVA Larynxcancer AJCC v8
- Stadie IVA Oropharyngeal (p16-negativ) karcinom AJCC v8
- Stadie IVB Hypopharyngeal Carcinom AJCC v8
- Stadie IVB Larynxcancer AJCC v8
- Stadie IVB Orofaryngeal (p16-negativ) karcinom AJCC v8
- Metastatisk hoved- og halskarcinom
- Karcinom af ukendt primær
- Metastatisk malign neoplasma i livmoderhalsen
- Stadie I Hypopharyngeal Carcinom AJCC v8
- Stadie I Nasopharyngeal Carcinoma AJCC v8
- Stadie II Hypopharyngeal Carcinom AJCC v8
- Fase II Larynxcancer AJCC v8
- Fase II Nasopharyngeal Carcinoma AJCC v8
- Fase II Oropharyngeal (p16-negativ) karcinom AJCC v8
- Stadie III Nasopharyngeal Carcinoma AJCC v8
Intervention / Behandling
Detaljeret beskrivelse
PRIMARY OBJECTIVES:
I. To determine whether illness perceptions significantly predict adherence to swallowing exercises at 6 months after the end of radiation.
II. To determine whether sickness behaviors (depression, fatigue, pain)'s effect on illness perceptions are mediated by pro-inflammatory cytokines.
III. To determine whether social support moderates the impact of coping on appraisal of coping.
SECONDARY OBJECTIVES:
I. As a secondary aim, to determine the feasibility and utility of cardiac impedance pre-ejection period measurement as a corollary measure for depression and distress.
II. As a secondary aim, to identify potential genetic markers for swallowing dysfunction which has developed by the 6-month follow-up.
OUTLINE:
Participants provide blood samples prior to and at the 6-month visit after receiving radiation therapy. Participants also complete questionnaires either at home, in clinic, or via internet over 30 minutes prior to receiving radiation therapy and within 14 days of blood sample collection.
After completion of study, participants are followed up periodically for up to 2 years.
Undersøgelsestype
Tilmelding (Anslået)
Kontakter og lokationer
Studiesteder
-
-
Texas
-
Houston, Texas, Forenede Stater, 77030
- Rekruttering
- M D Anderson Cancer Center
-
Kontakt:
- Eileen H. Shinn
- Telefonnummer: 713-745-0870
-
Ledende efterforsker:
- Eileen H. Shinn
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Participants with head and neck cancer
Beskrivelse
Inclusion Criteria:
- Are dispositioned to receive radiation with curative intent for nasopharyngeal, oropharyngeal, hypopharyngeal, laryngeal, or an unknown primary cancer with cervical metastases
- Are stage II-IVb for non- human papillomavirus (HPV)- related oropharyngeal cancer
- Have HPV- related oropharynx cancer that is T1, have nodal involvement with no distant metastasis or have HPV- related oropharynx cancer that is at least T2 with no distant metastasis
- Are stage II-IVb for laryngeal cancer
- Are stage I-IVb for hypopharyngeal
- Are stage I-IVb for nasopharyngeal cancer
- Have stage I-III unknown primary cancer with cervical
Exclusion Criteria:
- Have other cancer diagnoses, except non-melanoma skin cancer
- Had treatment for previous head and neck cancer or radiation to the head and neck
- Have a history of previous head and neck surgery (excluding biopsy and/or tonsillectomy and/or tracheotomy)
- Have a current oropharyngeal dysphagia unrelated to cancer diagnosis (e.g., dysphagia due to underlying neurogenic disorder)
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: COHORT
- Tidsperspektiver: PROSPECTIVE
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
|---|---|
|
Observational (blood tests, questionnaires)
Participants provide blood samples prior to and at the 6-month visit after receiving radiation therapy. Participants also complete questionnaires either at home, in clinic, or via internet over 30 minutes prior to receiving radiation therapy and within 14 days of blood sample collection. |
Ancillary studies Provide blood samples |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Adherence to swallowing exercises
Tidsramme: Up to 6 months
|
The primary analytic approach is to use linear mixed models to determine whether illness perceptions significantly predict adherence 6 months. The study will estimate and test the illness perception subscale scores' relationship to adherence using a linear mixed model. In the model, the dependent variable is the patient's self-reported adherence score and independent variables include illness perception, follow-up assessment time point and other covariates such as demographic and medical variables, depression, pain, fatigue, emotional coping, objective coping, appraisal of coping, stress, and lack of social well-being. |
Up to 6 months
|
|
Illness perceptions
Tidsramme: Up to 6 months
|
The study's statistical tool is mediation analysis: the independent variables are the sickness behaviors (depression, fatigue, pain); the mediators are the cytokine levels, and the outcome variable is illness perception. The study will test the mediator effects based on the product of coefficients method, rather than the classical Baron & Kenny causal steps tests, since the former approach has better statistical power. The study will conduct both single-mediator analysis for each of the mediators, and multiple-mediator analysis with all mediators in the mediating process |
Up to 6 months
|
|
Effect of social support on coping
Tidsramme: Up to 6 months
|
The moderating effect of social support on coping and appraisal of coping is the statistical equivalent of testing the two-way interaction between these variables and the social support variable. Multivariate linear regression will be used, in which the dependent variable is appraisal of coping at 6 months follow-up, and independent variables include the emotion-focused coping and action-focused sub scales, social support, and their two-way interactions. In the regression, the study will control for baseline variables. In addition, we will also apply the linear mixed model to investigate the moderating effect of these variables longitudinally. The mixed model naturally accounts for the correlation of repeated measures at baseline and 6 months follow-up. |
Up to 6 months
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Eileen H Shinn, M.D. Anderson Cancer Center
Publikationer og nyttige links
Hjælpsomme links
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Anslået)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Stomatognatiske sygdomme
- Patologiske processer
- Neoplasmer efter sted
- Neoplasmer
- Luftvejssygdomme
- Neoplasmer efter histologisk type
- Neoplasmer i hoved og hals
- Neoplasmer, kirtel og epitel
- Neoplasmer i luftvejene
- Neoplastiske processer
- Otorhinolaryngologiske sygdomme
- Pharyngeale neoplasmer
- Otorhinolaryngologiske neoplasmer
- Nasopharyngeale sygdomme
- Pharyngeale sygdomme
- Laryngeale sygdomme
- Neoplasma Metastase
- Nasopharyngeale neoplasmer
- Patologiske tilstande, tegn og symptomer
- Nasopharyngealt karcinom
- Karcinom
- Laryngeale neoplasmer
- Orofaryngeale neoplasmer
- Neoplasmer, ukendt primær
- Hypopharyngeale neoplasmer
Andre undersøgelses-id-numre
- 2016-0597
- 2016-0597 (Anden identifikator: M D Anderson Cancer Center)
- NCI-2018-01260 (Registry Identifier: CTRP (Clinical Trial Reporting Program))
- R21DE019954 (U.S. NIH-bevilling/kontrakt)
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .